These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28154102)

  • 21. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.
    Patti G; Pelliccia F; Gaudio C; Greco C
    Am J Cardiol; 2015 Mar; 115(6):837-43. PubMed ID: 25620037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary prevention of ischaemic stroke.
    Muller C; Roizman M; Wong A
    Intern Med J; 2019 Oct; 49(10):1221-1228. PubMed ID: 31602772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale.
    Arauz A; Murillo L; Márquez JM; Tamayo A; Cantú C; Roldan FJ; Vargas-Barrón J; Barinagarrementeria F
    Int J Stroke; 2012 Dec; 7(8):631-4. PubMed ID: 21978242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microembolic signals in patients with cryptogenic stroke with or without patent foramen ovale.
    Shariat A; Yaghoubi E; Nemati R; Moaref AR; Aghasadeghi K; Borhani Haghighi A
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):662-6. PubMed ID: 21459615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Fisher M; Hill JA
    Circulation; 2018 Jan; 137(2):103-105. PubMed ID: 29311344
    [No Abstract]   [Full Text] [Related]  

  • 28. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptogenic stroke, aortic arch atheroma and patent foramen ovale.
    Molina CA; Santamarina E; Alvarez-Sabín J
    Cerebrovasc Dis; 2007; 24 Suppl 1():84-8. PubMed ID: 17971642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptogenic stroke - How to make sense of a non-diagnostic entity.
    Schulz UG
    Maturitas; 2019 Apr; 122():44-50. PubMed ID: 30797529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and Management of Cardioembolic Stroke.
    Yaghi S
    Continuum (Minneap Minn); 2023 Apr; 29(2):462-485. PubMed ID: 37039405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.
    Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR
    Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current perspectives on the clinical management of cryptogenic stroke.
    Yang D; Elkind MSV
    Expert Rev Neurother; 2023 Mar; 23(3):213-226. PubMed ID: 36934333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL;
    N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!
    Windecker S; Meier B
    Circulation; 2008 Nov; 118(19):1989-98. PubMed ID: 18981313
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex differences in cryptogenic stroke with patent foramen ovale.
    Nedeltchev K; Wiedmer S; Schwerzmann M; Windecker S; Haefeli T; Meier B; Mattle HP; Arnold M
    Am Heart J; 2008 Sep; 156(3):461-5. PubMed ID: 18760126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current evidence for closure of a patent foramen ovale for cryptogenic stroke prevention.
    Rhone E; Chung N; Clapp B
    Int J Clin Pract; 2014 May; 68(5):551-6. PubMed ID: 24373020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.